Tekla Life Sciences Investors (HQL)

Tekla Life Sciences Investors (HQL) is an Asset Management company in the Financial Services sector listed on the NYSE.

As of Oct 23, 2026: market cap $547M; returns 1 day -1.2%, 1 week +5.7%, 1 year +8.2%.

Tekla Life Sciences Investors (HQL) is a closed-end fund (CEF) managed by abrdn (formerly Tekla Capital Management) that invests primarily in equity securities of companies in the life sciences industry, including biotechnology, pharmaceuticals, medical devices, and healthcare services.

HQL financial model: income statement, cash flow and balance sheet